A. Smith

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

F. Solé, A. Karsan, T. Haferlach, 2015, Blood Cancer Journal.

Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes

S. Nahas, J. Lancet, T. Cluzeau, 2016, Leukemia.

Preclinical modeling of myelodysplastic syndromes

G. Mufti, A. Abarrategi, P. Fenaux, 2017, Leukemia.

High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS)

G. Mufti, T. Gaymes, R. Ireland, 2015, Leukemia.

PWE-232 ADAMDEC1: a novel molecule in inflammation and bowel disease

G. Sewell, A. Segal, A. Smith, 2012, Gut.